Metsera, Inc. (NASDAQ:MTSR – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Metsera in a report issued on Thursday ...

March 31 (Reuters) - Analysts at Cantor Fitzgerald, formerly headed by the Trump administration's Secretary of Commerce Howard Lutnick, called for the dismissal of Secretary of Health and Human ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The main detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

Cantor Fitzgerald has a “Overweight” rating and a $7.00 price objective on the stock. The consensus estimate for Mereo BioPharma Group’s current full-year earnings is ($0.03) per share. Get ...

We are delighted to announce Siobhán Talbot will receive the Lifetime Achievement Award at the annual IMAGE PwC Businesswoman ...

(Reuters) - Analysts at Cantor Fitzgerald, formerly headed by the Trump administration's Secretary Of Commerce Howard Lutnick, called for the dismissal of Secretary of Health and Human Services Robert ...

Cantor Fitzgerald biotech analysts slammed the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., calling on the Trump administration to “re-evaluate” his role after a ...

On Friday, Cantor Fitzgerald reiterated its Overweight rating on Compass Pathways plc (NASDAQ:CMPS), a life sciences company focused on developing psilocybin therapy for mental health conditions.